NCT01847066

Epidermal Delivery of Ani-Aging Ingredients

Fractional Erbium 2940nm Laser & Impact US for Trans-Epidermal Delivery of Cosmetic Anti-Aging Ingredients for Wrinkles, Acne Scars and Pigmented Skin: A Randomized Split Face & Dorsal Hand Side by Side Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (estimated)
• Sponsor: Alma Lasers Inc. · Industry
• Sex: All
• Age: 35 Years – 65 Years
• Healthy volunteers: Accepted

Summary

To assess the safety and efficacy of an ablative fractional, 2940-nm laser combined with the US Impact and cosmetic -formulations for improving the appearance of wrinkles, acne scars and pigmented skin.

Detailed description

This is a randomized, split face \& dorsal hand side by side study. The purpose of the side by side study is to determine whether the use of the Impact with the ablative fractional 2940nm laser and cosmetics improves the cosmetic outcomes when compared to using just the ablative fractional 2940nm laser with the cosmetics. This is a non-significant risk aesthetic clinical study. Only cosmetic formulations will be used during the study, These cosmetic formulations do not contain any ingredient categorized as a drug by the FDA.

Conditions

• Wrinkles
• Acne Scars
• Pigmentation

Interventions

Type	Name	Description
DEVICE	Erbium 2940 plus cosmetics plus Impact	Laser used in all arms
DEVICE	Erbium 2940 plus cosmetics	laser

Timeline

• Start date: 2013-05-01
• Primary completion: 2013-09-01
• Completion: 2013-09-01
• First posted: 2013-05-06
• Last updated: 2013-05-06

Locations

1 site across 1 country: United States